Guardant Health, Inc. vs Abbvie Inc.
GH vs ABBV — side-by-side comparison from reported financials. GH leads 3, ABBV leads 5 of 8 comparable metrics.
Guardant Health, Inc.
GH · Healthcare
$167.40+1.11%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | GH | ABBV |
|---|---|---|
| Price | $167.40 | $276.43 |
| Market cap | $22.5B | $488B |
| Revenue (TTM) | $1.18B | $64.4B |
| Revenue growth | +29.8% | +1.8% |
| Net margin | -38.3% | 9.8% |
| Free cash flow | -$241M | $18.2B |
| Net cash (debt) | — | ($56.2B) |
| 1-year price return | +156.5% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | — | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -247% | 96% |
| Altman Z-score | 4.47 | 2.33 |
| CV checks passed | 5 of 9 | 9 of 9 |
| Employees | 2,506 | 57,000 |
Full résumé-style profiles: GH CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.